Troikaa Pharmaceuticals Ltd, an Ahmedabad-based pharmaceutical firm has been granted a patent this week for ‘Dynapar AQ’, a painkiller injection, in the Commonwealth of Independent States also known as the CIS block. The CIS countries include Ukraine, Kazakhastan, Belarus, Uzbekistan, Turkmenistan, Kyrgystan, Russia among others.
Last year Australia had granted a patent for Dynapar AQ to Troikaa Pharma; Australia being the first regulated markets for this drug. Similar patent applications are pending in the United States, EU and Canada.
Diclofenac injections are used for treating painful inflammatory conditions. Dynapar AQ is a high concentration and low viscosity injection of diclofenac sodium which delivers the full curative dose of diclofenac in just one milliliter injection. It is the only diclofenac injection available in PFS (pre-filled syringe) form and causes minor pain. It has a 40 per cent market share in Diclofenac injections being sold in India
(Source: http://www.itagbs.com/)
No comments:
Post a Comment